BridgeMD
New treatment option for Chronic Hemiparetic Stroke
Official title Movement Amplification Gait Training to Enhance Walking Balance Post-Stroke
ClinicalTrials.gov ID: NCT06400186
What this study is testing
- What it's testing
- Stroke is a leading cause of disability in the United States, affecting approximately 795,000 people annually. The Veteran's Health Administration provides over 60,000 outpatient visits for stroke-related care annually at a cost of over $250 million.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- History of chronic stroke (more than 6 months post-stroke) with weakness on one side
- Ability to ambulate over ground for 10 meters with or without a single cane, and/or ankle-foot orthosis
- Ability to tolerate 10 minutes of standing
You likely can't join if
- Presence of cognitive impairment (score of 22/30 on the Montreal Cognitive Assessment scale (MoCA))
- Presence of aphasia (score of 71/100 on the Mississippi Aphasia Screening Test (MAST))
- Excessive spasticity in lower limbs (score of \> 3 on the Modified Ashworth Scale
- Severe cardiovascular and pulmonary disease affecting gait and balance
- History of recurrent fractures or known orthopedic problems in the lower extremities (i.e. heterotopic ossification) affecting gait and balance
- Concomitant central or peripheral neurological injury (i.e. traumatic head injury or peripheral nerve damage in lower limbs) affecting gait and...
See the full eligibility criteria
- History of chronic stroke (more than 6 months post-stroke) with weakness on one side
- Ability to ambulate over ground for 10 meters with or without a single cane, and/or ankle-foot orthosis
- Ability to tolerate 10 minutes of standing
- Presence of cognitive impairment (score of 22/30 on the Montreal Cognitive Assessment scale (MoCA))
- Presence of aphasia (score of 71/100 on the Mississippi Aphasia Screening Test (MAST))
- Excessive spasticity in lower limbs (score of \> 3 on the Modified Ashworth Scale
- Severe cardiovascular and pulmonary disease affecting gait and balance
- History of recurrent fractures or known orthopedic problems in the lower extremities (i.e. heterotopic ossification) affecting gait and balance
- Concomitant central or peripheral neurological injury (i.e. traumatic head injury or peripheral nerve damage in lower limbs) affecting gait and balance
- Evidence of cerebellar ataxia
- Presence of unhealed decubiti or other skin compromise
- Enrollment in concurrent physical therapy or research involving gait or balance training
- Use of braces/orthotics crossing the knee joint
- Known pregnancy
The study team makes the final eligibility decision.
Where it's taking place
- Chicago, Illinois, United States
- Hines, Illinois, United States
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chicago, Illinois, United States; Hines, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.